The narcotic analgesics have an important role in the perioperative management of surgical patients - preoperatively as hypnotics, intraoperatively as sole or adjuvant anesthetics and postoperatively for pain relief. With increasing age, there is a well demonstrated decrease of the narcotic dose requirement. Because narcotics have a narrow therapeutic index and an age-related change of dose requirement, the safe use of narcotics in the aged can become clinically difficult. This research will develop a pharmacodynamic model that relates the morphine or fentanyl plasma concentration to the degree of narcotic effect on the brain. The narcotic-induced slowing of the electroencephalogram (EEG) will be used as a noninvasive, continuous measure of the drug effect ot estimate an individual patient's brain sensitivity. The pharmacokinetics of morphine and fentanyl will be determined in surgical patients aged 20-90 years old to see if increasing age and its physiological alterations effect pharmacokinetic variables, such as the degree of protein binding, the rate or extent of narcotic distribution or the rate of elimination from the body. The pharmacodynamics of morphine and fentanyl will be determined in surgical patients, aged 20-90 years using the above indicated EEG measures of narcotic brain effect. Pharmacodynamic modelling will be used to relate the narcotic plasma concentrations to the drug induced EEG changed and to determine if aging alters the onset, degree of (brain sensitivity) and duration of morphine/fentanyl CNS effect. The above research will be used to provide better scientific guidelines for the clinical use of morphine and fentanyl in the aged surgical patient. By determining the mechanism of the altered narcotic dose requirement with increasing age in man, subsequent animal and in vivo pharmacology can more specifically be directed to obtain biochemical and molecular explanations of the effects of aging on narcotic response.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG004594-04
Application #
3115233
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1984-01-01
Project End
1990-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Bjorkman, S; Wada, D R; Stanski, D R (1998) Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 88:657-67
Wada, D R; Bjorkman, S; Ebling, W F et al. (1997) Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87:884-99
Harashima, H; Ebling, W F; Wada, D R et al. (1997) No effect of age on the dose requirement of thiopental in the rat. Exp Gerontol 32:315-24
Wada, D R; Harashima, H; Ebling, W et al. (1996) Effects of thiopental on regional blood flows in the rat. Anesthesiology 84:596-604
MacIver, M B; Mandema, J W; Stanski, D R et al. (1996) Thiopental uncouples hippocampal and cortical synchronized electroencephalographic activity. Anesthesiology 84:1411-24
Wada, D R; Stanski, D R; Ebling, W F (1995) A PC-based graphical simulator for physiological pharmacokinetic models. Comput Methods Programs Biomed 46:245-55
Bjorkman, S; Wada, D R; Stanski, D R et al. (1994) Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J Pharmacokinet Biopharm 22:381-410
Burm, A G; Ausems, M E; Spierdijk, J et al. (1993) Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery. Eur J Anaesthesiol 10:241-51
Bjorkman, S; Stanski, D R; Harashima, H et al. (1993) Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. J Pharmacokinet Biopharm 21:255-79
Verotta, D; Sheiner, L B (1991) Semiparametric analysis of non-steady-state pharmacodynamic data. J Pharmacokinet Biopharm 19:691-712

Showing the most recent 10 out of 28 publications